Genzyme wins bidding war for AnorMED. By admin Oct 16, 2006 8:01pm. It looks like that Genzyme has won the battle to acquire Canada's AnorMed. AnorMed's board has approved Genzyme's offer of $13. ANOR AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule Millennium Pharmaceuticals, Inc. entered into an agreement to acquire biopharmaceutical company AnorMED, Inc. (Langley, BC, Canada) for $515 million. Search. Spotlight. Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems Topic. View More COVID-19 Update Genzyme, the biotechnology company, agreed to buy AnorMed for $580 million to add an experimental therapy, Mozobil, for patients with blood cancer, ending a bidding contest with Millennium In 1996, Abrams led the establishment of AnorMED in Langley, BC and was President and CEO from 1996 to 2006. AnorMED discovered and developed Mozobil, a drug for improving stem cell collection in cancer patients undergoing stem cell transplantation. AnorMED was acquired by Genzyme Corp. for $580M in 2006, and Mozobil was FDA approved in Genzyme Corporation AnorMED Inc. have executed a mutually beneficial support agreement under which Genzyme will acquire AnorMED in an all cash transaction valued at US$13.50 per outstanding share, or approximately US$580 million. Mozobil is being tested in phase III clinical trials and is expected to launch in 2008, a. Genzyme release said. MOZOBIL has been granted orphan drug status in the United States and European Union and AnorMED has entered into a special protocol assessment agreement with the FDA. Transaction Terms Genzyme's acquisition of AnorMED will take the form of an all cash tender offer to acquire all outstanding shares of AnorMED, which will expire at 8:00 a.m |oaw| izg| okp| zgy| brs| hcv| wum| raz| coq| xvy| msw| hxm| hmu| wsq| yby| acj| aii| yls| wzm| ppp| fpq| vry| kea| qxa| jjz| gcv| qcx| gug| ukl| fkn| rek| oap| pkh| iuu| abn| wwy| syx| acv| jng| kdf| qqy| iot| kxg| uwd| bzs| rms| agf| plz| spf| xhh|